Cite
HARVARD Citation
Charlesworth, J. et al. (2021). Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children. Pediatric blood & cancer. 68 (9), p. n/a. [Online].